0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Neurodegenerative Disease Market Insights, Forecast to 2030
Published Date: September 2024
|
Report Code: QYRE-Auto-37Z1691
Home | Market Reports | Health| Health Conditions| Neurological Conditions
Global Neurodegenerative Disease Market Size Status and Forecast 2021 2027
BUY CHAPTERS

Global Neurodegenerative Disease Market Insights, Forecast to 2030

Code: QYRE-Auto-37Z1691
Report
September 2024
Pages:116
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

Neurodegenerative Disease Market Size

The global Neurodegenerative Disease market is projected to grow from US$ 7239.3 million in 2024 to US$ 8704 million by 2030, at a Compound Annual Growth Rate (CAGR) of 3.1% during the forecast period.

Neurodegenerative Disease Market

Neurodegenerative Disease Market

Neurodegenerative diseases are a group of disorders characterized by the progressive degeneration of the structure and function of the nervous system, leading to cognitive and motor impairments. Examples include Alzheimer's disease, Parkinson's disease, and amyotrophic lateral sclerosis (ALS).
Market Analysis and Insights: Global Neurodegenerative Disease Market
The market for neurodegenerative disease treatments and management is driven by the increasing prevalence of these diseases, particularly with an aging population. The market's growth is also influenced by the demand for disease-modifying therapies and symptom management options to improve the quality of life for patients.
Report Covers:
This report presents an overview of global market for Neurodegenerative Disease market size. Analyses of the global market trends, with historic market revenue data for 2019 - 2023, estimates for 2024, and projections of CAGR through 2030.
This report researches the key producers of Neurodegenerative Disease, also provides the revenue of main regions and countries. Highlights of the upcoming market potential for Neurodegenerative Disease, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Neurodegenerative Disease revenue, market share and industry ranking of main companies, data from 2019 to 2024. Identification of the major stakeholders in the global Neurodegenerative Disease market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by Type and by Application, revenue, and growth rate, from 2019 to 2030. Evaluation and forecast the market size for Neurodegenerative Disease revenue, projected growth trends, production technology, application and end-user industry.
Market Segmentation

Scope of Neurodegenerative Disease Market Report

Report Metric Details
Report Name Neurodegenerative Disease Market
Accounted market size in 2024 US$ 7239.3 million
Forecasted market size in 2030 US$ 8704 million
CAGR 3.1
Base Year 2024
Forecasted years 2024 - 2030
Segment by Type
  • NMDA
  • SSRIs
  • Dopamine Inhibitors
Segment by Application
  • Parkinson’s Disease
  • Huntington Disease
  • Amyotrophic Lateral Sclerosis
  • Alzheimer’s Disease
By Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company Novartis, Pfizer, Merck Serono, Biogen Idec, TEVA, UCB, Boehringer Ingelheim, Sanofi, GlaxoSmithKline, Livzon Pharmaceutical, Haisco Pharmaceutical, Jingxin Pharmaceutical, Dongcheng Biochemicals, Hisun Pharmaceutical, Luye Pharma, Ark Pharmaceutical, Kanghong Pharmaceutical, Huahai Pharmaceutical, BORA PHARMACEUTICALS
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Revenue of Neurodegenerative Disease in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. This section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
  • Chapter 3: Detailed analysis of Neurodegenerative Disease companies’ competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6: North America (US & Canada) by Type, by Application and by country, revenue for each segment.
  • Chapter 7: Europe by Type, by Application and by country, revenue for each segment.
  • Chapter 8: China by Type, and by Application, revenue for each segment.
  • Chapter 9: Asia (excluding China) by Type, by Application and by region, revenue for each segment.
  • Chapter 10: Middle East, Africa, and Latin America by Type, by Application and by country, revenue for each segment.
  • Chapter 11: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Neurodegenerative Disease revenue, gross margin, and recent development, etc.
  • Chapter 12: Analyst's Viewpoints/Conclusions

FAQ for this report

How fast is Neurodegenerative Disease Market growing?

Ans: The Neurodegenerative Disease Market witnessing a CAGR of 3.1 during the forecast period 2024-2030.

What is the Neurodegenerative Disease Market size in 2030?

Ans: The Neurodegenerative Disease Market size in 2030 will be US$ 8704 million.

Who are the main players in the Neurodegenerative Disease Market report?

Ans: The main players in the Neurodegenerative Disease Market are Novartis, Pfizer, Merck Serono, Biogen Idec, TEVA, UCB, Boehringer Ingelheim, Sanofi, GlaxoSmithKline, Livzon Pharmaceutical, Haisco Pharmaceutical, Jingxin Pharmaceutical, Dongcheng Biochemicals, Hisun Pharmaceutical, Luye Pharma, Ark Pharmaceutical, Kanghong Pharmaceutical, Huahai Pharmaceutical, BORA PHARMACEUTICALS

What are the Application segmentation covered in the Neurodegenerative Disease Market report?

Ans: The Applications covered in the Neurodegenerative Disease Market report are Parkinson’s Disease, Huntington Disease, Amyotrophic Lateral Sclerosis, Alzheimer’s Disease

What are the Type segmentation covered in the Neurodegenerative Disease Market report?

Ans: The Types covered in the Neurodegenerative Disease Market report are NMDA, SSRIs, Dopamine Inhibitors

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Neurodegenerative Disease Market Size Growth Rate by Type, 2019 VS 2023 VS 2030
1.2.2 NMDA
1.2.3 SSRIs
1.2.4 Dopamine Inhibitors
1.3 Market by Application
1.3.1 Global Neurodegenerative Disease Market Size Growth Rate by Application, 2019 VS 2023 VS 2030
1.3.2 Parkinson’s Disease
1.3.3 Huntington Disease
1.3.4 Amyotrophic Lateral Sclerosis
1.3.5 Alzheimer’s Disease
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Neurodegenerative Disease Market Perspective (2019-2030)
2.2 Global Neurodegenerative Disease Growth Trends by Region
2.2.1 Neurodegenerative Disease Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Neurodegenerative Disease Historic Market Size by Region (2019-2024)
2.2.3 Neurodegenerative Disease Forecasted Market Size by Region (2025-2030)
2.3 Neurodegenerative Disease Market Dynamics
2.3.1 Neurodegenerative Disease Industry Trends
2.3.2 Neurodegenerative Disease Market Drivers
2.3.3 Neurodegenerative Disease Market Challenges
2.3.4 Neurodegenerative Disease Market Restraints
3 Competition Landscape by Key Players
3.1 Global Revenue Neurodegenerative Disease by Players
3.1.1 Global Neurodegenerative Disease Revenue by Players (2019-2024)
3.1.2 Global Neurodegenerative Disease Revenue Market Share by Players (2019-2024)
3.2 Global Neurodegenerative Disease Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players of Neurodegenerative Disease, Ranking by Revenue, 2022 VS 2023 VS 2024
3.4 Global Neurodegenerative Disease Market Concentration Ratio
3.4.1 Global Neurodegenerative Disease Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Neurodegenerative Disease Revenue in 2023
3.5 Global Key Players of Neurodegenerative Disease Head office and Area Served
3.6 Global Key Players of Neurodegenerative Disease, Product and Application
3.7 Global Key Players of Neurodegenerative Disease, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Neurodegenerative Disease Breakdown Data by Type
4.1 Global Neurodegenerative Disease Historic Market Size by Type (2019-2024)
4.2 Global Neurodegenerative Disease Forecasted Market Size by Type (2025-2030)
5 Neurodegenerative Disease Breakdown Data by Application
5.1 Global Neurodegenerative Disease Historic Market Size by Application (2019-2024)
5.2 Global Neurodegenerative Disease Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Neurodegenerative Disease Market Size (2019-2030)
6.2 North America Neurodegenerative Disease Market Size by Type
6.2.1 North America Neurodegenerative Disease Market Size by Type (2019-2024)
6.2.2 North America Neurodegenerative Disease Market Size by Type (2025-2030)
6.2.3 North America Neurodegenerative Disease Market Share by Type (2019-2030)
6.3 North America Neurodegenerative Disease Market Size by Application
6.3.1 North America Neurodegenerative Disease Market Size by Application (2019-2024)
6.3.2 North America Neurodegenerative Disease Market Size by Application (2025-2030)
6.3.3 North America Neurodegenerative Disease Market Share by Application (2019-2030)
6.4 North America Neurodegenerative Disease Market Size by Country
6.4.1 North America Neurodegenerative Disease Market Size by Country: 2019 VS 2023 VS 2030
6.4.2 North America Neurodegenerative Disease Market Size by Country (2019-2024)
6.4.3 North America Neurodegenerative Disease Market Size by Country (2025-2030)
6.4.4 United States
6.4.5 Canada
7 Europe
7.1 Europe Neurodegenerative Disease Market Size (2019-2030)
7.2 Europe Neurodegenerative Disease Market Size by Type
7.2.1 Europe Neurodegenerative Disease Market Size by Type (2019-2024)
7.2.2 Europe Neurodegenerative Disease Market Size by Type (2025-2030)
7.2.3 Europe Neurodegenerative Disease Market Share by Type (2019-2030)
7.3 Europe Neurodegenerative Disease Market Size by Application
7.3.1 Europe Neurodegenerative Disease Market Size by Application (2019-2024)
7.3.2 Europe Neurodegenerative Disease Market Size by Application (2025-2030)
7.3.3 Europe Neurodegenerative Disease Market Share by Application (2019-2030)
7.4 Europe Neurodegenerative Disease Market Size by Country
7.4.1 Europe Neurodegenerative Disease Market Size by Country: 2019 VS 2023 VS 2030
7.4.2 Europe Neurodegenerative Disease Market Size by Country (2019-2024)
7.4.3 Europe Neurodegenerative Disease Market Size by Country (2025-2030)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic Countries
8 China
8.1 China Neurodegenerative Disease Market Size (2019-2030)
8.2 China Neurodegenerative Disease Market Size by Type
8.2.1 China Neurodegenerative Disease Market Size by Type (2019-2024)
8.2.2 China Neurodegenerative Disease Market Size by Type (2025-2030)
8.2.3 China Neurodegenerative Disease Market Share by Type (2019-2030)
8.3 China Neurodegenerative Disease Market Size by Application
8.3.1 China Neurodegenerative Disease Market Size by Application (2019-2024)
8.3.2 China Neurodegenerative Disease Market Size by Application (2025-2030)
8.3.3 China Neurodegenerative Disease Market Share by Application (2019-2030)
9 Asia (excluding China)
9.1 Asia Neurodegenerative Disease Market Size (2019-2030)
9.2 Asia Neurodegenerative Disease Market Size by Type
9.2.1 Asia Neurodegenerative Disease Market Size by Type (2019-2024)
9.2.2 Asia Neurodegenerative Disease Market Size by Type (2025-2030)
9.2.3 Asia Neurodegenerative Disease Market Share by Type (2019-2030)
9.3 Asia Neurodegenerative Disease Market Size by Application
9.3.1 Asia Neurodegenerative Disease Market Size by Application (2019-2024)
9.3.2 Asia Neurodegenerative Disease Market Size by Application (2025-2030)
9.3.3 Asia Neurodegenerative Disease Market Share by Application (2019-2030)
9.4 Asia Neurodegenerative Disease Market Size by Region
9.4.1 Asia Neurodegenerative Disease Market Size by Region: 2019 VS 2023 VS 2030
9.4.2 Asia Neurodegenerative Disease Market Size by Region (2019-2024)
9.4.3 Asia Neurodegenerative Disease Market Size by Region (2025-2030)
9.4.4 Japan
9.4.5 South Korea
9.4.6 China Taiwan
9.4.7 Southeast Asia
9.4.8 India
9.4.9 Australia
10 Middle East, Africa, and Latin America
10.1 Middle East, Africa, and Latin America Neurodegenerative Disease Market Size (2019-2030)
10.2 Middle East, Africa, and Latin America Neurodegenerative Disease Market Size by Type
10.2.1 Middle East, Africa, and Latin America Neurodegenerative Disease Market Size by Type (2019-2024)
10.2.2 Middle East, Africa, and Latin America Neurodegenerative Disease Market Size by Type (2025-2030)
10.2.3 Middle East, Africa, and Latin America Neurodegenerative Disease Market Share by Type (2019-2030)
10.3 Middle East, Africa, and Latin America Neurodegenerative Disease Market Size by Application
10.3.1 Middle East, Africa, and Latin America Neurodegenerative Disease Market Size by Application (2019-2024)
10.3.2 Middle East, Africa, and Latin America Neurodegenerative Disease Market Size by Application (2025-2030)
10.3.3 Middle East, Africa, and Latin America Neurodegenerative Disease Market Share by Application (2019-2030)
10.4 Middle East, Africa, and Latin America Neurodegenerative Disease Market Size by Country
10.4.1 Middle East, Africa, and Latin America Neurodegenerative Disease Market Size by Country: 2019 VS 2023 VS 2030
10.4.2 Middle East, Africa, and Latin America Neurodegenerative Disease Market Size by Country (2019-2024)
10.4.3 Middle East, Africa, and Latin America Neurodegenerative Disease Market Size by Country (2025-2030)
10.4.4 Brazil
10.4.5 Mexico
10.4.6 Turkey
10.4.7 Saudi Arabia
10.4.8 Israel
10.4.9 GCC Countries
11 Key Players Profiles
11.1 Novartis
11.1.1 Novartis Company Details
11.1.2 Novartis Business Overview
11.1.3 Novartis Neurodegenerative Disease Introduction
11.1.4 Novartis Revenue in Neurodegenerative Disease Business (2019-2024)
11.1.5 Novartis Recent Developments
11.2 Pfizer
11.2.1 Pfizer Company Details
11.2.2 Pfizer Business Overview
11.2.3 Pfizer Neurodegenerative Disease Introduction
11.2.4 Pfizer Revenue in Neurodegenerative Disease Business (2019-2024)
11.2.5 Pfizer Recent Developments
11.3 Merck Serono
11.3.1 Merck Serono Company Details
11.3.2 Merck Serono Business Overview
11.3.3 Merck Serono Neurodegenerative Disease Introduction
11.3.4 Merck Serono Revenue in Neurodegenerative Disease Business (2019-2024)
11.3.5 Merck Serono Recent Developments
11.4 Biogen Idec
11.4.1 Biogen Idec Company Details
11.4.2 Biogen Idec Business Overview
11.4.3 Biogen Idec Neurodegenerative Disease Introduction
11.4.4 Biogen Idec Revenue in Neurodegenerative Disease Business (2019-2024)
11.4.5 Biogen Idec Recent Developments
11.5 TEVA
11.5.1 TEVA Company Details
11.5.2 TEVA Business Overview
11.5.3 TEVA Neurodegenerative Disease Introduction
11.5.4 TEVA Revenue in Neurodegenerative Disease Business (2019-2024)
11.5.5 TEVA Recent Developments
11.6 UCB
11.6.1 UCB Company Details
11.6.2 UCB Business Overview
11.6.3 UCB Neurodegenerative Disease Introduction
11.6.4 UCB Revenue in Neurodegenerative Disease Business (2019-2024)
11.6.5 UCB Recent Developments
11.7 Boehringer Ingelheim
11.7.1 Boehringer Ingelheim Company Details
11.7.2 Boehringer Ingelheim Business Overview
11.7.3 Boehringer Ingelheim Neurodegenerative Disease Introduction
11.7.4 Boehringer Ingelheim Revenue in Neurodegenerative Disease Business (2019-2024)
11.7.5 Boehringer Ingelheim Recent Developments
11.8 Sanofi
11.8.1 Sanofi Company Details
11.8.2 Sanofi Business Overview
11.8.3 Sanofi Neurodegenerative Disease Introduction
11.8.4 Sanofi Revenue in Neurodegenerative Disease Business (2019-2024)
11.8.5 Sanofi Recent Developments
11.9 GlaxoSmithKline
11.9.1 GlaxoSmithKline Company Details
11.9.2 GlaxoSmithKline Business Overview
11.9.3 GlaxoSmithKline Neurodegenerative Disease Introduction
11.9.4 GlaxoSmithKline Revenue in Neurodegenerative Disease Business (2019-2024)
11.9.5 GlaxoSmithKline Recent Developments
11.10 Livzon Pharmaceutical
11.10.1 Livzon Pharmaceutical Company Details
11.10.2 Livzon Pharmaceutical Business Overview
11.10.3 Livzon Pharmaceutical Neurodegenerative Disease Introduction
11.10.4 Livzon Pharmaceutical Revenue in Neurodegenerative Disease Business (2019-2024)
11.10.5 Livzon Pharmaceutical Recent Developments
11.11 Haisco Pharmaceutical
11.11.1 Haisco Pharmaceutical Company Details
11.11.2 Haisco Pharmaceutical Business Overview
11.11.3 Haisco Pharmaceutical Neurodegenerative Disease Introduction
11.11.4 Haisco Pharmaceutical Revenue in Neurodegenerative Disease Business (2019-2024)
11.11.5 Haisco Pharmaceutical Recent Developments
11.12 Jingxin Pharmaceutical
11.12.1 Jingxin Pharmaceutical Company Details
11.12.2 Jingxin Pharmaceutical Business Overview
11.12.3 Jingxin Pharmaceutical Neurodegenerative Disease Introduction
11.12.4 Jingxin Pharmaceutical Revenue in Neurodegenerative Disease Business (2019-2024)
11.12.5 Jingxin Pharmaceutical Recent Developments
11.13 Dongcheng Biochemicals
11.13.1 Dongcheng Biochemicals Company Details
11.13.2 Dongcheng Biochemicals Business Overview
11.13.3 Dongcheng Biochemicals Neurodegenerative Disease Introduction
11.13.4 Dongcheng Biochemicals Revenue in Neurodegenerative Disease Business (2019-2024)
11.13.5 Dongcheng Biochemicals Recent Developments
11.14 Hisun Pharmaceutical
11.14.1 Hisun Pharmaceutical Company Details
11.14.2 Hisun Pharmaceutical Business Overview
11.14.3 Hisun Pharmaceutical Neurodegenerative Disease Introduction
11.14.4 Hisun Pharmaceutical Revenue in Neurodegenerative Disease Business (2019-2024)
11.14.5 Hisun Pharmaceutical Recent Developments
11.15 Luye Pharma
11.15.1 Luye Pharma Company Details
11.15.2 Luye Pharma Business Overview
11.15.3 Luye Pharma Neurodegenerative Disease Introduction
11.15.4 Luye Pharma Revenue in Neurodegenerative Disease Business (2019-2024)
11.15.5 Luye Pharma Recent Developments
11.16 Ark Pharmaceutical
11.16.1 Ark Pharmaceutical Company Details
11.16.2 Ark Pharmaceutical Business Overview
11.16.3 Ark Pharmaceutical Neurodegenerative Disease Introduction
11.16.4 Ark Pharmaceutical Revenue in Neurodegenerative Disease Business (2019-2024)
11.16.5 Ark Pharmaceutical Recent Developments
11.17 Kanghong Pharmaceutical
11.17.1 Kanghong Pharmaceutical Company Details
11.17.2 Kanghong Pharmaceutical Business Overview
11.17.3 Kanghong Pharmaceutical Neurodegenerative Disease Introduction
11.17.4 Kanghong Pharmaceutical Revenue in Neurodegenerative Disease Business (2019-2024)
11.17.5 Kanghong Pharmaceutical Recent Developments
11.18 Huahai Pharmaceutical
11.18.1 Huahai Pharmaceutical Company Details
11.18.2 Huahai Pharmaceutical Business Overview
11.18.3 Huahai Pharmaceutical Neurodegenerative Disease Introduction
11.18.4 Huahai Pharmaceutical Revenue in Neurodegenerative Disease Business (2019-2024)
11.18.5 Huahai Pharmaceutical Recent Developments
11.19 BORA PHARMACEUTICALS
11.19.1 BORA PHARMACEUTICALS Company Details
11.19.2 BORA PHARMACEUTICALS Business Overview
11.19.3 BORA PHARMACEUTICALS Neurodegenerative Disease Introduction
11.19.4 BORA PHARMACEUTICALS Revenue in Neurodegenerative Disease Business (2019-2024)
11.19.5 BORA PHARMACEUTICALS Recent Developments
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
List of Tables
    Table 1. Global Neurodegenerative Disease Market Size Growth Rate by Type (US$ Million), 2019 VS 2023 VS 2030
    Table 2. Key Players of NMDA
    Table 3. Key Players of SSRIs
    Table 4. Key Players of Dopamine Inhibitors
    Table 5. Global Neurodegenerative Disease Market Size Growth Rate by Application (US$ Million), 2019 VS 2023 VS 2030
    Table 6. Global Neurodegenerative Disease Market Size Growth Rate (CAGR) by Region (US$ Million): 2019 VS 2023 VS 2030
    Table 7. Global Neurodegenerative Disease Market Size by Region (2019-2024) & (US$ Million)
    Table 8. Global Neurodegenerative Disease Market Share by Region (2019-2024)
    Table 9. Global Neurodegenerative Disease Forecasted Market Size by Region (2025-2030) & (US$ Million)
    Table 10. Global Neurodegenerative Disease Market Share by Region (2025-2030)
    Table 11. Neurodegenerative Disease Market Trends
    Table 12. Neurodegenerative Disease Market Drivers
    Table 13. Neurodegenerative Disease Market Challenges
    Table 14. Neurodegenerative Disease Market Restraints
    Table 15. Global Neurodegenerative Disease Revenue by Players (2019-2024) & (US$ Million)
    Table 16. Global Neurodegenerative Disease Revenue Share by Players (2019-2024)
    Table 17. Global Top Neurodegenerative Disease by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Neurodegenerative Disease as of 2023)
    Table 18. Global Neurodegenerative Disease Industry Ranking 2022 VS 2023 VS 2024
    Table 19. Global 5 Largest Players Market Share by Neurodegenerative Disease Revenue (CR5 and HHI) & (2019-2024)
    Table 20. Global Key Players of Neurodegenerative Disease, Headquarters and Area Served
    Table 21. Global Key Players of Neurodegenerative Disease, Product and Application
    Table 22. Global Key Players of Neurodegenerative Disease, Product and Application
    Table 23. Mergers & Acquisitions, Expansion Plans
    Table 24. Global Neurodegenerative Disease Market Size by Type (2019-2024) & (US$ Million)
    Table 25. Global Neurodegenerative Disease Revenue Market Share by Type (2019-2024)
    Table 26. Global Neurodegenerative Disease Forecasted Market Size by Type (2025-2030) & (US$ Million)
    Table 27. Global Neurodegenerative Disease Revenue Market Share by Type (2025-2030)
    Table 28. Global Neurodegenerative Disease Market Size by Application (2019-2024) & (US$ Million)
    Table 29. Global Neurodegenerative Disease Revenue Share by Application (2019-2024)
    Table 30. Global Neurodegenerative Disease Forecasted Market Size by Application (2025-2030) & (US$ Million)
    Table 31. Global Neurodegenerative Disease Revenue Share by Application (2025-2030)
    Table 32. North America Neurodegenerative Disease Market Size by Type (2019-2024) & (US$ Million)
    Table 33. North America Neurodegenerative Disease Market Size by Type (2025-2030) & (US$ Million)
    Table 34. North America Neurodegenerative Disease Market Size by Application (2019-2024) & (US$ Million)
    Table 35. North America Neurodegenerative Disease Market Size by Application (2025-2030) & (US$ Million)
    Table 36. North America Neurodegenerative Disease Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030
    Table 37. North America Neurodegenerative Disease Market Size by Country (2019-2024) & (US$ Million)
    Table 38. North America Neurodegenerative Disease Market Size by Country (2025-2030) & (US$ Million)
    Table 39. Europe Neurodegenerative Disease Market Size by Type (2019-2024) & (US$ Million)
    Table 40. Europe Neurodegenerative Disease Market Size by Type (2025-2030) & (US$ Million)
    Table 41. Europe Neurodegenerative Disease Market Size by Application (2019-2024) & (US$ Million)
    Table 42. Europe Neurodegenerative Disease Market Size by Application (2025-2030) & (US$ Million)
    Table 43. Europe Neurodegenerative Disease Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030
    Table 44. Europe Neurodegenerative Disease Market Size by Country (2019-2024) & (US$ Million)
    Table 45. Europe Neurodegenerative Disease Market Size by Country (2025-2030) & (US$ Million)
    Table 46. China Neurodegenerative Disease Market Size by Type (2019-2024) & (US$ Million)
    Table 47. China Neurodegenerative Disease Market Size by Type (2025-2030) & (US$ Million)
    Table 48. China Neurodegenerative Disease Market Size by Application (2019-2024) & (US$ Million)
    Table 49. China Neurodegenerative Disease Market Size by Application (2025-2030) & (US$ Million)
    Table 50. Asia Neurodegenerative Disease Market Size by Type (2019-2024) & (US$ Million)
    Table 51. Asia Neurodegenerative Disease Market Size by Type (2025-2030) & (US$ Million)
    Table 52. Asia Neurodegenerative Disease Market Size by Application (2019-2024) & (US$ Million)
    Table 53. Asia Neurodegenerative Disease Market Size by Application (2025-2030) & (US$ Million)
    Table 54. Asia Neurodegenerative Disease Growth Rate (CAGR) by Region (US$ Million): 2019 VS 2023 VS 2030
    Table 55. Asia Neurodegenerative Disease Market Size by Region (2019-2024) & (US$ Million)
    Table 56. Asia Neurodegenerative Disease Market Size by Region (2025-2030) & (US$ Million)
    Table 57. Middle East, Africa, and Latin America Neurodegenerative Disease Market Size by Type (2019-2024) & (US$ Million)
    Table 58. Middle East, Africa, and Latin America Neurodegenerative Disease Market Size by Type (2025-2030) & (US$ Million)
    Table 59. Middle East, Africa, and Latin America Neurodegenerative Disease Market Size by Application (2019-2024) & (US$ Million)
    Table 60. Middle East, Africa, and Latin America Neurodegenerative Disease Market Size by Application (2025-2030) & (US$ Million)
    Table 61. Middle East, Africa, and Latin America Neurodegenerative Disease Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030
    Table 62. Middle East, Africa, and Latin America Neurodegenerative Disease Market Size by Country (2019-2024) & (US$ Million)
    Table 63. Middle East, Africa, and Latin America Neurodegenerative Disease Market Size by Country (2025-2030) & (US$ Million)
    Table 64. Novartis Company Details
    Table 65. Novartis Business Overview
    Table 66. Novartis Neurodegenerative Disease Product
    Table 67. Novartis Revenue in Neurodegenerative Disease Business (2019-2024) & (US$ Million)
    Table 68. Novartis Recent Developments
    Table 69. Pfizer Company Details
    Table 70. Pfizer Business Overview
    Table 71. Pfizer Neurodegenerative Disease Product
    Table 72. Pfizer Revenue in Neurodegenerative Disease Business (2019-2024) & (US$ Million)
    Table 73. Pfizer Recent Developments
    Table 74. Merck Serono Company Details
    Table 75. Merck Serono Business Overview
    Table 76. Merck Serono Neurodegenerative Disease Product
    Table 77. Merck Serono Revenue in Neurodegenerative Disease Business (2019-2024) & (US$ Million)
    Table 78. Merck Serono Recent Developments
    Table 79. Biogen Idec Company Details
    Table 80. Biogen Idec Business Overview
    Table 81. Biogen Idec Neurodegenerative Disease Product
    Table 82. Biogen Idec Revenue in Neurodegenerative Disease Business (2019-2024) & (US$ Million)
    Table 83. Biogen Idec Recent Developments
    Table 84. TEVA Company Details
    Table 85. TEVA Business Overview
    Table 86. TEVA Neurodegenerative Disease Product
    Table 87. TEVA Revenue in Neurodegenerative Disease Business (2019-2024) & (US$ Million)
    Table 88. TEVA Recent Developments
    Table 89. UCB Company Details
    Table 90. UCB Business Overview
    Table 91. UCB Neurodegenerative Disease Product
    Table 92. UCB Revenue in Neurodegenerative Disease Business (2019-2024) & (US$ Million)
    Table 93. UCB Recent Developments
    Table 94. Boehringer Ingelheim Company Details
    Table 95. Boehringer Ingelheim Business Overview
    Table 96. Boehringer Ingelheim Neurodegenerative Disease Product
    Table 97. Boehringer Ingelheim Revenue in Neurodegenerative Disease Business (2019-2024) & (US$ Million)
    Table 98. Boehringer Ingelheim Recent Developments
    Table 99. Sanofi Company Details
    Table 100. Sanofi Business Overview
    Table 101. Sanofi Neurodegenerative Disease Product
    Table 102. Sanofi Revenue in Neurodegenerative Disease Business (2019-2024) & (US$ Million)
    Table 103. Sanofi Recent Developments
    Table 104. GlaxoSmithKline Company Details
    Table 105. GlaxoSmithKline Business Overview
    Table 106. GlaxoSmithKline Neurodegenerative Disease Product
    Table 107. GlaxoSmithKline Revenue in Neurodegenerative Disease Business (2019-2024) & (US$ Million)
    Table 108. GlaxoSmithKline Recent Developments
    Table 109. Livzon Pharmaceutical Company Details
    Table 110. Livzon Pharmaceutical Business Overview
    Table 111. Livzon Pharmaceutical Neurodegenerative Disease Product
    Table 112. Livzon Pharmaceutical Revenue in Neurodegenerative Disease Business (2019-2024) & (US$ Million)
    Table 113. Livzon Pharmaceutical Recent Developments
    Table 114. Haisco Pharmaceutical Company Details
    Table 115. Haisco Pharmaceutical Business Overview
    Table 116. Haisco Pharmaceutical Neurodegenerative Disease Product
    Table 117. Haisco Pharmaceutical Revenue in Neurodegenerative Disease Business (2019-2024) & (US$ Million)
    Table 118. Haisco Pharmaceutical Recent Developments
    Table 119. Jingxin Pharmaceutical Company Details
    Table 120. Jingxin Pharmaceutical Business Overview
    Table 121. Jingxin Pharmaceutical Neurodegenerative Disease Product
    Table 122. Jingxin Pharmaceutical Revenue in Neurodegenerative Disease Business (2019-2024) & (US$ Million)
    Table 123. Jingxin Pharmaceutical Recent Developments
    Table 124. Dongcheng Biochemicals Company Details
    Table 125. Dongcheng Biochemicals Business Overview
    Table 126. Dongcheng Biochemicals Neurodegenerative Disease Product
    Table 127. Dongcheng Biochemicals Revenue in Neurodegenerative Disease Business (2019-2024) & (US$ Million)
    Table 128. Dongcheng Biochemicals Recent Developments
    Table 129. Hisun Pharmaceutical Company Details
    Table 130. Hisun Pharmaceutical Business Overview
    Table 131. Hisun Pharmaceutical Neurodegenerative Disease Product
    Table 132. Hisun Pharmaceutical Revenue in Neurodegenerative Disease Business (2019-2024) & (US$ Million)
    Table 133. Hisun Pharmaceutical Recent Developments
    Table 134. Luye Pharma Company Details
    Table 135. Luye Pharma Business Overview
    Table 136. Luye Pharma Neurodegenerative Disease Product
    Table 137. Luye Pharma Revenue in Neurodegenerative Disease Business (2019-2024) & (US$ Million)
    Table 138. Luye Pharma Recent Developments
    Table 139. Ark Pharmaceutical Company Details
    Table 140. Ark Pharmaceutical Business Overview
    Table 141. Ark Pharmaceutical Neurodegenerative Disease Product
    Table 142. Ark Pharmaceutical Revenue in Neurodegenerative Disease Business (2019-2024) & (US$ Million)
    Table 143. Ark Pharmaceutical Recent Developments
    Table 144. Kanghong Pharmaceutical Company Details
    Table 145. Kanghong Pharmaceutical Business Overview
    Table 146. Kanghong Pharmaceutical Neurodegenerative Disease Product
    Table 147. Kanghong Pharmaceutical Revenue in Neurodegenerative Disease Business (2019-2024) & (US$ Million)
    Table 148. Kanghong Pharmaceutical Recent Developments
    Table 149. Huahai Pharmaceutical Company Details
    Table 150. Huahai Pharmaceutical Business Overview
    Table 151. Huahai Pharmaceutical Neurodegenerative Disease Product
    Table 152. Huahai Pharmaceutical Revenue in Neurodegenerative Disease Business (2019-2024) & (US$ Million)
    Table 153. Huahai Pharmaceutical Recent Developments
    Table 154. BORA PHARMACEUTICALS Company Details
    Table 155. BORA PHARMACEUTICALS Business Overview
    Table 156. BORA PHARMACEUTICALS Neurodegenerative Disease Product
    Table 157. BORA PHARMACEUTICALS Revenue in Neurodegenerative Disease Business (2019-2024) & (US$ Million)
    Table 158. BORA PHARMACEUTICALS Recent Developments
    Table 159. Research Programs/Design for This Report
    Table 160. Key Data Information from Secondary Sources
    Table 161. Key Data Information from Primary Sources
List of Figures
    Figure 1. Global Neurodegenerative Disease Market Size Growth Rate by Type, 2019 VS 2023 VS 2030 (US$ Million)
    Figure 2. Global Neurodegenerative Disease Market Share by Type: 2023 VS 2030
    Figure 3. NMDA Features
    Figure 4. SSRIs Features
    Figure 5. Dopamine Inhibitors Features
    Figure 6. Global Neurodegenerative Disease Market Size Growth Rate by Application, 2019 VS 2023 VS 2030 (US$ Million)
    Figure 7. Global Neurodegenerative Disease Market Share by Application: 2023 VS 2030
    Figure 8. Parkinson’s Disease Case Studies
    Figure 9. Huntington Disease Case Studies
    Figure 10. Amyotrophic Lateral Sclerosis Case Studies
    Figure 11. Alzheimer’s Disease Case Studies
    Figure 12. Neurodegenerative Disease Report Years Considered
    Figure 13. Global Neurodegenerative Disease Market Size (US$ Million), Year-over-Year: 2019-2030
    Figure 14. Global Neurodegenerative Disease Market Size, (US$ Million), 2019 VS 2023 VS 2030
    Figure 15. Global Neurodegenerative Disease Market Share by Region: 2023 VS 2030
    Figure 16. Global Neurodegenerative Disease Market Share by Players in 2023
    Figure 17. Global Top Neurodegenerative Disease Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Neurodegenerative Disease as of 2023)
    Figure 18. The Top 10 and 5 Players Market Share by Neurodegenerative Disease Revenue in 2023
    Figure 19. North America Neurodegenerative Disease Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 20. North America Neurodegenerative Disease Market Share by Type (2019-2030)
    Figure 21. North America Neurodegenerative Disease Market Share by Application (2019-2030)
    Figure 22. North America Neurodegenerative Disease Market Share by Country (2019-2030)
    Figure 23. United States Neurodegenerative Disease Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 24. Canada Neurodegenerative Disease Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 25. Europe Neurodegenerative Disease Market Size YoY (2019-2030) & (US$ Million)
    Figure 26. Europe Neurodegenerative Disease Market Share by Type (2019-2030)
    Figure 27. Europe Neurodegenerative Disease Market Share by Application (2019-2030)
    Figure 28. Europe Neurodegenerative Disease Market Share by Country (2019-2030)
    Figure 29. Germany Neurodegenerative Disease Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 30. France Neurodegenerative Disease Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 31. U.K. Neurodegenerative Disease Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 32. Italy Neurodegenerative Disease Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 33. Russia Neurodegenerative Disease Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 34. Nordic Countries Neurodegenerative Disease Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 35. China Neurodegenerative Disease Market Size YoY (2019-2030) & (US$ Million)
    Figure 36. China Neurodegenerative Disease Market Share by Type (2019-2030)
    Figure 37. China Neurodegenerative Disease Market Share by Application (2019-2030)
    Figure 38. Asia Neurodegenerative Disease Market Size YoY (2019-2030) & (US$ Million)
    Figure 39. Asia Neurodegenerative Disease Market Share by Type (2019-2030)
    Figure 40. Asia Neurodegenerative Disease Market Share by Application (2019-2030)
    Figure 41. Asia Neurodegenerative Disease Market Share by Region (2019-2030)
    Figure 42. Japan Neurodegenerative Disease Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 43. South Korea Neurodegenerative Disease Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 44. China Taiwan Neurodegenerative Disease Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 45. Southeast Asia Neurodegenerative Disease Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 46. India Neurodegenerative Disease Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 47. Australia Neurodegenerative Disease Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 48. Middle East, Africa, and Latin America Neurodegenerative Disease Market Size YoY (2019-2030) & (US$ Million)
    Figure 49. Middle East, Africa, and Latin America Neurodegenerative Disease Market Share by Type (2019-2030)
    Figure 50. Middle East, Africa, and Latin America Neurodegenerative Disease Market Share by Application (2019-2030)
    Figure 51. Middle East, Africa, and Latin America Neurodegenerative Disease Market Share by Country (2019-2030)
    Figure 52. Brazil Neurodegenerative Disease Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 53. Mexico Neurodegenerative Disease Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 54. Turkey Neurodegenerative Disease Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 55. Saudi Arabia Neurodegenerative Disease Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 56. Israel Neurodegenerative Disease Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 57. GCC Countries Neurodegenerative Disease Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 58. Novartis Revenue Growth Rate in Neurodegenerative Disease Business (2019-2024)
    Figure 59. Pfizer Revenue Growth Rate in Neurodegenerative Disease Business (2019-2024)
    Figure 60. Merck Serono Revenue Growth Rate in Neurodegenerative Disease Business (2019-2024)
    Figure 61. Biogen Idec Revenue Growth Rate in Neurodegenerative Disease Business (2019-2024)
    Figure 62. TEVA Revenue Growth Rate in Neurodegenerative Disease Business (2019-2024)
    Figure 63. UCB Revenue Growth Rate in Neurodegenerative Disease Business (2019-2024)
    Figure 64. Boehringer Ingelheim Revenue Growth Rate in Neurodegenerative Disease Business (2019-2024)
    Figure 65. Sanofi Revenue Growth Rate in Neurodegenerative Disease Business (2019-2024)
    Figure 66. GlaxoSmithKline Revenue Growth Rate in Neurodegenerative Disease Business (2019-2024)
    Figure 67. Livzon Pharmaceutical Revenue Growth Rate in Neurodegenerative Disease Business (2019-2024)
    Figure 68. Haisco Pharmaceutical Revenue Growth Rate in Neurodegenerative Disease Business (2019-2024)
    Figure 69. Jingxin Pharmaceutical Revenue Growth Rate in Neurodegenerative Disease Business (2019-2024)
    Figure 70. Dongcheng Biochemicals Revenue Growth Rate in Neurodegenerative Disease Business (2019-2024)
    Figure 71. Hisun Pharmaceutical Revenue Growth Rate in Neurodegenerative Disease Business (2019-2024)
    Figure 72. Luye Pharma Revenue Growth Rate in Neurodegenerative Disease Business (2019-2024)
    Figure 73. Ark Pharmaceutical Revenue Growth Rate in Neurodegenerative Disease Business (2019-2024)
    Figure 74. Kanghong Pharmaceutical Revenue Growth Rate in Neurodegenerative Disease Business (2019-2024)
    Figure 75. Huahai Pharmaceutical Revenue Growth Rate in Neurodegenerative Disease Business (2019-2024)
    Figure 76. BORA PHARMACEUTICALS Revenue Growth Rate in Neurodegenerative Disease Business (2019-2024)
    Figure 77. Bottom-up and Top-down Approaches for This Report
    Figure 78. Data Triangulation
    Figure 79. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$4900

This license allows only one user to access the PDF.
Electronic (PDF)

$7350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$9800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

Lukasiewicz Research Network

SIMILAR REPORTS

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 

RELATED REPORTS

Epilepsy Monitoring Equipment - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

120 Pages
Type: Report
Code: QYRE-Auto-26C10310
Fri Nov 22 00:00:00 UTC 2024

Add to Cart

Central Nervous System (CNS) Drug - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

120 Pages
Type: Report
Code: QYRE-Auto-19Y8825
Mon Nov 18 00:00:00 UTC 2024

Add to Cart

Neurosurgical Skull Clamps - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

120 Pages
Type: Report
Code: QYRE-Auto-11T9549
Fri Nov 15 00:00:00 UTC 2024

Add to Cart

Global Nerve Conduction Threshold (sNCT) Device Market Research Report 2024

120 Pages
Type: Report
Code: QYRE-Auto-37T18607
Fri Nov 15 00:00:00 UTC 2024

Add to Cart